Navigation Links
StatSure Diagnostic Systems, Inc. (OTC Bulletin Board: SSUR) Review Issued By Scimitar Equity Research, Inc.
Date:10/26/2007

BOSTON, Oct. 26 /PRNewswire/ -- Scimitar Equity Research, Inc. (Scimitar) issues a review of StatSure Diagnostic Systems, Inc. (OTC Bulletin Board: SSUR), entitled, "Opportunity Unfolds for Investors Seeking to Participate In a Proprietary Point-of-Care Firm".

This review is available at our website: http://www.scimitarequity.com.

ABOUT STATSURE

StatSure Diagnostic Systems, Inc. is engaged in the development, manufacture and marketing of rapid immunoassay tests for the detection of sexually transmitted and other infectious diseases; in addition, the Company has developed and is marketing a product line of patented, oral- fluid collection devices. The Company's proprietary platforms provide significant customer benefits and competitive advantages as compared to similar products that are currently available. Improved accuracy, operator convenience, and reduced risk of infection from collecting and handling specimens, have been engineered into SDS products. All of the company's diagnostic tests are based on the same easy-to-use technology platform, thus facilitating the development of future products. Certain of these products are sold in the United States as well as internationally to various distributors for use in clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations. Please visit our website at http://www.StatSure.com

ABOUT Scimitar Equity Research, Inc.

Scimitar Equity Research, Inc. provides sponsored equity research of the health sciences industry for the institutional and investment communities. We certify that all the views expressed in this review, accurately reflect our personal views about SSUR.OB (OTC Bulletin Board) and its or their securities. No part of our compensation was, is, or will be, directly or indirectly, related to the specific recommendations
'/>"/>

SOURCE Scimitar Equity Research, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. New diagnostic marker for prostate cancer
2. Cancer Risk From Exposure To Diagnostic X-Rays
3. Fragile X-Associated Tremor /Ataxia Syndrome Need Guidelines For Diagnostic Tests
4. Schizophrenia Gets A New Diagnostic Tool
5. MRI as a diagnostic tool for breast cancer
6. A New Diagnostic Approach To Pediatric Interstitial Lung Disease
7. Diagnostic Procedure For Tuberculosis Made Easy
8. Apollo Hospitals Short-listed to Provide Diagnostics in the UK
9. Mammography units and up gradation and tax cuts on diagnostic equipments in Hospitals
10. SRL Ranbaxy offers quicker bird flu diagnostic test
11. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... young athletes are under increasing pressure to p...a University Health System study of 519 junior ten...reases the risk of injury. Researchers who analyze...n junior competition found that players who specia...from tournaments for medical reasons, typically in...
(Date:11/8/2009)...Newswire-USNewswire/ -- Jon O,Brien, president of ...nt about the passage of HR 3962: ,, "Behavior ... lot about core values. We in the prochoice commun...rcome the struggles ordinary Americans have making...afford basic healthcare or have to choose between ...
(Date:11/8/2009)...ition promotes self-assurance, research finds , ...mother may have been right when she told you to si...ture could make you feel more confident about your...ing up straight gives a good impression to other p...a psychology professor at Ohio State University, s...
(Date:11/8/2009)...Newswire-USNewswire/ -- Speaker Nancy Pelosi and D...g the House passage of H.R. 3962, the Affordable H...vote of 220 to 215. Below are the Speaker,s openi...st received a call from the President of the Unite...at victory for the American people. I thank the Pr...
(Date:11/8/2009)...eeze-drying of biopharmaceuticals to be available ...ty. , Toronto, ON (PRWEB...d CEO of Therapure Biopharma Inc. today announced ...l scale pharmaceutical grade freeze dryer and expe...lization) available for contract manufacturing of ...
Breaking Medicine News(10 mins):Health News:Young tennis players who play only 1 sport are more prone to injuries 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:Good Posture May Inspire Confidence 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2
...o receive a vaccine to protect them against severe... are less likely to contract a serious disease, ac...rvard Medical School studied more than 740 childre... -- a bacterium that causes a person to become res...
...snapshot of the nation's health, put together by t...ws that nearly a third of Americans are obese //an...rth continues to rise, reaching a new record high ...om 1990. The life expectancy for boys born in 2001...
...with men and cars? Why doesn't he notice how much ...ep a grip on the remote control? And the most bewi...me? The answers, says social philosopher Michae...the technology to prove it. "What Could He Be T...
...and its symptoms have been shown to accelerate dea...ooked at the elderly in particular. // A new s...g in the community and not in assisted-living faci...e presence of depression and then did so again at ...
...e tells us high heeled shoes are not good for the ...that assumption. British researchers find no relat...opment of knee osteoarthritis.// About 2 perce... has led investigators to speculate a lifetime of ...
...a popular herbal supplement thought to have anti-c...sical and mental abilities, and help people cope w...rly used by pregnant women, particularly in Asian ...f pregnant women were taking herbal supplements, i...
Other Medicine News:Health News:Diabetes, obesity rates shooting up 2Health News:How a man's mind really works 2
(Date:11/6/2009)...e-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin B...ta-based, biopharmaceutical company developing hum...munodeficiency Virus) and other infectious agents,...results and provided an operational update. ,, ...ve Officer commented, "We are pleased with our pro...
(Date:11/6/2009)...e-FirstCall/ -- Caraco Pharmaceutical Laboratories...romethamine ophthalmic solution, 0.5% following a ...ation (FDA) for Sun Pharma,s Abbreviated New Drug ...mic solution on the first day following patent exp...ally equivalent to Acular® Ophthalmic Solutio...
(Date:11/6/2009)...ewswire/ -- , - Trial Will Compare NXL103...nt of Multi-Resistant Staphylococcus Aureus (MRSA)...aceutical company focused on the discovery and,dev... the significant global,problem of microbial resis...,antibacterial NXL103 (flopristin/linopristin), ha...
Breaking Medicine Technology:GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4New Complimentary Wallet Card to Tackle Concussions Head On 58903 1New Complimentary Wallet Card to Tackle Concussions Head On 58903 2CTIA West Wireless Health Institute Qualcomm and CommNexus San Diego Present 3A San Diego The Nations Hub for Wireless Healthcare 58900 1CTIA West Wireless Health Institute Qualcomm and CommNexus San Diego Present 3A San Diego The Nations Hub for Wireless Healthcare 58900 2Verenium Announces Proposed Public Offering of Common Stock 14359 1Verenium Announces Proposed Public Offering of Common Stock 14359 2Verenium Announces Proposed Public Offering of Common Stock 14359 3
...ESS WIRE)--Jun 11, 2007 - Opexa,Therapeutics, Inc....ent and commercialization of cell therapies, made ...f the Federation of,Clinical Immunology Societies ... Diego Hotel & Marina. The poster, entitled,"I...elapsing,Remitting Multiple Sclerosis Patients" wa...
...tudy Presented at Federation of,Clinical Immunolog...lif., June 11, 2007 /PRNewswire-FirstCall/ --,Orch...nounced today,positive new data from its completed...estigational T Cell Receptor (TCR) peptide,vaccine... sclerosis,(MS). The new data, presented last week...
Other Medicine Technology:Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 2Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 3Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 2Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 3Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 5
Shandon Pathcentre Netmon Service
Shandon Excelsior Tissue Processor
Shandon Gross-Star Grossing Workbench
Shandon Hyperclean 20 Fume Handling Station
Medicine Products: